---
title: "Paolo De Luca Sells 13,835 Shares of Organigram Holdings Inc. (TSE:OGI) Stock"
description: "Paolo De Luca, a Senior Officer at Organigram Holdings Inc. (TSE:OGI), sold 13,835 shares of the company's stock on September 11th at an average price of C$0.54, totaling C$7,440.90. Post-sale, he own"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/214322596.md"
published_at: "2024-09-13T20:36:54.000Z"
---

# Paolo De Luca Sells 13,835 Shares of Organigram Holdings Inc. (TSE:OGI) Stock

> Paolo De Luca, a Senior Officer at Organigram Holdings Inc. (TSE:OGI), sold 13,835 shares of the company's stock on September 11th at an average price of C$0.54, totaling C$7,440.90. Post-sale, he owns 625 shares valued at approximately C$587.50. Previously, on August 16th, he sold 10,266 shares at C$0.76. Organigram's stock performance shows a market cap of C$68 million, with a PE ratio of -1.00 and a 52-week range of C$0.35 to C$0.95. Analysts have mixed ratings on the stock, with some lowering and others raising price targets.

Organigram Holdings Inc. (TSE:OGI - Get Free Report) Senior Officer Paolo De Luca sold 13,835 shares of the firm's stock in a transaction dated Wednesday, September 11th. The stock was sold at an average price of C$2.54, for a total value of C$35,140.90. Following the completion of the sale, the insider now directly owns 625 shares of the company's stock, valued at approximately C$1,587.50.

Paolo De Luca also recently made the following trade(s):

-   On Friday, August 16th, Paolo De Luca sold 10,266 shares of Organigram stock. The stock was sold at an average price of C$2.76, for a total value of C$28,334.16.

## Organigram Stock Performance

OGI stock traded up C$0.04 during midday trading on Friday, reaching C$2.53. The stock had a trading volume of 258,414 shares, compared to its average volume of 319,274. The firm has a fifty day simple moving average of C$2.37 and a two-hundred day simple moving average of C$2.51. The stock has a market cap of C$274.68 million, a PE ratio of -1.00, a P/E/G ratio of 0.42 and a beta of 1.13. The company has a debt-to-equity ratio of 1.13, a quick ratio of 2.62 and a current ratio of 6.95. Organigram Holdings Inc. has a 52-week low of C$1.35 and a 52-week high of C$3.95.

Organigram (TSE:OGI - Get Free Report) last posted its earnings results on Tuesday, August 13th. The company reported C$0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of C($0.07) by C$0.10. Organigram had a negative net margin of 153.80% and a negative return on equity of 54.53%. The firm had revenue of C$41.06 million during the quarter, compared to analysts' expectations of C$39.20 million. As a group, equities research analysts anticipate that Organigram Holdings Inc. will post 0.1735254 EPS for the current year.

## Analyst Ratings Changes

OGI has been the subject of several recent analyst reports. Jefferies Financial Group lowered their price target on Organigram from C$4.40 to C$4.35 in a report on Friday, May 17th. Canaccord Genuity Group raised their target price on Organigram from C$3.25 to C$3.60 and gave the stock a "speculative buy" rating in a research note on Wednesday, August 14th.

**Check Out Our Latest Research Report on Organigram**

## Organigram Company Profile

(Get Free Report)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.

## Featured Stories

-   Five stocks we like better than Organigram
-   What is a support level?
-   Powering Your Portfolio: The Utility Sector's Electrifying Surge
-   Are Penny Stocks a Good Fit for Your Portfolio?
-   Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
-   When to Sell a Stock for Profit or Loss
-   Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off

*This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.*

→ Invest before this deal closes on 9/18 (From Deal Maker) (Ad)## Should you invest $1,000 in Organigram right now?

Before you consider Organigram, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organigram wasn't on the list.

While Organigram currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

### Related Stocks

- [OGI.US - Organigram](https://longbridge.com/en/quote/OGI.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Organigram 宣佈擬收購德國領先的大麻公司 Sanity Group \| OGI 股票新聞 | Organigram 宣佈擬以 1.134 億歐元的預付款收購德國領先的大麻公司 Sanity Group，並根據業績可能獲得高達 1.138 億歐元的額外收益。這項收購旨在加強 Organigram 在全球大麻市場的地位，特別是在歐洲，S | [Link](https://longbridge.com/en/news/276220948.md) |
| Organigram 宣佈英美煙草公司以 6500 萬加元進行私募投資，以收購 Sanity Group \| BTI 股票新聞 | Organigram Global Inc. 宣佈獲得英美煙草子公司 BT DE Investments Inc. 的 6520 萬加元私人配售投資，以支持其收購 Sanity Group。該投資包括以每股 3.00 加元的價格購買股份，以 | [Link](https://longbridge.com/en/news/276326294.md) |
| Alliance Global Partners 重申對 OrganiGram Holdings (OGI) 的買入評級 | Alliance Global Partners 分析師 Aaron Grey 重新確認了對 OrganiGram Holdings (OGI) 的買入評級，目標價為 4.00 加元。Grey 的平均回報率為 -4.8%，成功率為 33.1 | [Link](https://longbridge.com/en/news/276266040.md) |
| Organigram Global Inc. 發佈了截至2025年12月31日的三個月管理層討論與分析（MD&A） | OrganiGram Global Inc. 報告稱，截至 2025 年 12 月 31 日的財政年度，國際銷售顯著增長，這歸因於生產和物流的改善。儘管國際銷售有所下降，公司在第四季度和第一季度維持了 38% 的調整後毛利率。其增長戰略專注 | [Link](https://longbridge.com/en/news/275459685.md) |
| Organigram Global Inc. 發佈了 2026 年第一季度的管理層討論與分析（MD&A）報告 | OrganiGram Global Inc. 報告稱國際需求不斷增加，並計劃擴大國際銷售，特別是在加拿大以外的地區加強活動，並通過對 Sanity Group 的投資進入德國大麻市場。公司預計其蒙克頓設施即將獲得的歐盟良好生產規範（EU-G | [Link](https://longbridge.com/en/news/275459714.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
